TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $993,488 | -47.7% | 118,856 | +55.4% | 0.00% | -66.7% |
| Q2 2023 | $1,901,346 | +128.2% | 76,483 | +38.7% | 0.00% | +50.0% |
| Q1 2023 | $833,277 | +93.8% | 55,143 | +51.3% | 0.00% | +100.0% |
| Q4 2022 | $430,000 | +140.2% | 36,447 | +19.7% | 0.00% | – |
| Q3 2022 | $179,000 | +26.1% | 30,440 | -8.0% | 0.00% | – |
| Q2 2022 | $142,000 | -56.7% | 33,103 | -3.9% | 0.00% | -100.0% |
| Q1 2022 | $328,000 | -25.6% | 34,433 | +49.5% | 0.00% | 0.0% |
| Q4 2021 | $441,000 | -62.1% | 23,027 | -34.1% | 0.00% | -50.0% |
| Q3 2021 | $1,164,000 | +3.3% | 34,924 | +20.3% | 0.00% | 0.0% |
| Q2 2021 | $1,127,000 | -5.0% | 29,025 | +17.9% | 0.00% | -33.3% |
| Q1 2021 | $1,186,000 | -4.3% | 24,621 | +3.4% | 0.00% | 0.0% |
| Q4 2020 | $1,239,000 | +33.7% | 23,801 | -31.2% | 0.00% | 0.0% |
| Q3 2020 | $927,000 | +104.2% | 34,587 | +48.9% | 0.00% | +50.0% |
| Q2 2020 | $454,000 | +69.4% | 23,231 | -14.4% | 0.00% | +100.0% |
| Q1 2020 | $268,000 | – | 27,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |